Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC
Clinical trial NCT04565054 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04565054
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2028-06-01
- Enrollment
- 1260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.